Your browser is no longer supported. Please, upgrade your browser.
Settings
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E40.60 EPS (ttm)2.13 Insider Own0.20% Shs Outstand509.00M Perf Week2.34%
Market Cap43.38B Forward P/E21.74 EPS next Y3.98 Insider Trans-6.35% Shs Float504.41M Perf Month8.34%
Income1.10B PEG4.51 EPS next Q0.64 Inst Own86.90% Short Float1.77% Perf Quarter8.10%
Sales11.67B P/S3.72 EPS this Y37.10% Inst Trans-1.26% Short Ratio3.26 Perf Half Y7.40%
Book/sh17.07 P/B5.07 EPS next Y17.00% ROA5.60% Target Price91.75 Perf Year-6.92%
Cash/sh7.44 P/C11.63 EPS next 5Y9.00% ROE13.30% 52W Range74.79 - 95.19 Perf YTD7.83%
Dividend0.98 P/FCF63.23 EPS past 5Y24.40% ROI8.60% 52W High-9.11% Beta0.67
Dividend %1.13% Quick Ratio1.90 Sales past 5Y3.20% Gross Margin39.70% 52W Low15.68% ATR1.27
Employees50000 Current Ratio2.50 Sales Q/Q4.70% Oper. Margin12.50% RSI (14)70.02 Volatility1.41% 1.66%
OptionableYes Debt/Eq0.71 EPS Q/Q181.80% Profit Margin9.40% Rel Volume0.99 Prev Close86.56
ShortableYes LT Debt/Eq0.67 EarningsApr 29 BMO Payout44.10% Avg Volume2.73M Price86.52
Recom2.10 SMA202.69% SMA507.45% SMA2006.61% Volume2,704,179 Change-0.05%
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $100 → $80
Jan-06-21Downgrade UBS Buy → Neutral $95 → $85
Dec-15-20Downgrade Goldman Buy → Neutral $96 → $85
Oct-01-20Upgrade Citigroup Neutral → Buy $94
Sep-04-20Downgrade Argus Buy → Hold
Jun-24-20Initiated Oppenheimer Outperform $100
Mar-19-20Upgrade Stifel Hold → Buy $87 → $95
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $92
Mar-05-20Initiated Citigroup Neutral $94
Feb-13-20Initiated Goldman Buy $104
Jan-02-20Upgrade Evercore ISI In-line → Outperform $80 → $94
Dec-17-19Downgrade Morgan Stanley Overweight → Equal-Weight $90 → $88
Jun-26-19Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19Downgrade Evercore ISI Outperform → In-line
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-02-19Upgrade Citigroup Neutral → Buy
Nov-02-18Upgrade Argus Hold → Buy
Oct-16-18Initiated Barclays Underweight $73
May-17-18Resumed Piper Jaffray Overweight $77
Feb-06-18Reiterated Citigroup Neutral $66 → $70
Apr-17-21 03:43AM  
Apr-12-21 03:58PM  
Apr-07-21 04:15PM  
Mar-30-21 04:15PM  
Mar-29-21 03:55PM  
10:00AM  
09:00AM  
Mar-24-21 04:15PM  
Mar-18-21 01:50AM  
Mar-16-21 08:56AM  
Mar-12-21 08:00AM  
Mar-10-21 04:15PM  
Mar-08-21 09:46AM  
09:21AM  
09:14AM  
09:00AM  
Mar-06-21 11:31AM  
Feb-26-21 05:07PM  
Feb-20-21 02:11AM  
Feb-18-21 01:09AM  
Feb-16-21 04:30PM  
09:00AM  
Feb-04-21 07:00PM  
09:29AM  
08:35AM  
07:41AM  
07:15AM  
Feb-01-21 09:43AM  
Jan-28-21 12:32PM  
Jan-23-21 01:41AM  
Jan-21-21 04:15PM  
Jan-12-21 09:09AM  
Jan-11-21 08:30AM  
Jan-05-21 04:15PM  
06:57AM  
Dec-23-20 11:32PM  
Dec-16-20 04:15PM  
Dec-09-20 11:55AM  
04:54AM  
Dec-08-20 05:56PM  
12:49PM  
Dec-07-20 08:05AM  
Dec-06-20 11:45AM  
Dec-03-20 08:00AM  
Dec-01-20 03:48PM  
Nov-30-20 01:44PM  
Nov-28-20 01:29AM  
Nov-27-20 12:00AM  
Nov-26-20 07:15AM  
Nov-24-20 08:00AM  
Nov-23-20 08:00AM  
Nov-18-20 04:15PM  
Nov-17-20 04:47PM  
Nov-16-20 04:15PM  
03:12PM  
08:25AM  
Nov-12-20 08:46AM  
Nov-11-20 08:11AM  
Nov-01-20 07:34AM  
Oct-30-20 03:01AM  
Oct-29-20 10:33AM  
10:21AM  
10:15AM  
07:39AM  
07:15AM  
06:30AM  
Oct-28-20 09:53AM  
Oct-27-20 09:00AM  
Oct-26-20 07:56AM  
Oct-21-20 06:54PM  
Oct-20-20 08:01AM  
Oct-16-20 03:30AM  
Oct-15-20 04:15PM  
Oct-14-20 08:07AM  
08:00AM  
07:05AM  
Sep-24-20 08:30AM  
Sep-23-20 08:00AM  
Sep-18-20 06:29AM  
Sep-16-20 09:00AM  
Sep-10-20 06:10PM  
Sep-09-20 06:47PM  
Sep-04-20 11:26AM  
Sep-03-20 08:00PM  
08:00PM  
Sep-02-20 05:26PM  
08:13AM  
Aug-31-20 02:15PM  
07:30AM  
Aug-29-20 11:31AM  
Aug-23-20 08:25AM  
Aug-20-20 04:15PM  
Aug-19-20 06:49PM  
04:15PM  
Aug-17-20 06:06AM  
Aug-16-20 02:34AM  
Aug-14-20 05:00PM  
Aug-12-20 09:00AM  
Aug-05-20 08:30AM  
Jul-31-20 09:45AM  
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Frye AndrewSVP, President, APACApr 12Sale84.7910,999932,6059,041Apr 14 04:04 PM
HELLMAN PETER SDirectorApr 05Option Exercise31.264,990155,98730,389Apr 07 06:55 PM
STROUCKEN ALBERT P LDirectorApr 05Option Exercise31.264,990155,98736,886Apr 07 06:57 PM
HELLMAN PETER SDirectorApr 05Sale84.564,990421,95425,399Apr 07 06:55 PM
STROUCKEN ALBERT P LDirectorApr 05Sale84.564,990421,95431,896Apr 07 06:57 PM
Martin SeanSVP and General CounselNov 02Option Exercise50.7747,0012,386,24186,641Nov 04 04:05 PM
Martin SeanSVP and General CounselNov 02Sale78.6747,0013,697,79439,640Nov 04 04:05 PM
FORSYTH JOHN DDirectorSep 14Option Exercise31.263109,69134,279Sep 15 04:07 PM
FORSYTH JOHN DDirectorSep 14Sale83.5931025,91333,969Sep 15 04:07 PM
GAVIN JAMES R IIIDirectorAug 03Option Exercise38.1414,899568,28954,407Aug 05 05:39 PM
GAVIN JAMES R IIIDirectorAug 03Sale86.4114,8991,287,36639,508Aug 05 05:39 PM
Accogli GiuseppeSVP, President, AmericasJun 19Option Exercise50.2370,7223,552,303138,861Jun 23 04:00 PM
Accogli GiuseppeSVP, President, AmericasJun 19Sale85.0072,3416,148,98566,520Jun 23 04:00 PM
FORSYTH JOHN DDirectorJun 15Option Exercise31.261,50046,89035,398Jun 17 04:02 PM
FORSYTH JOHN DDirectorJun 15Sale82.951,500124,42533,898Jun 17 04:02 PM
Franzi CristianoSVP, President, EMEAJun 08Option Exercise62.2346,6002,899,91885,688Jun 10 04:17 PM
Franzi CristianoSVP, President, EMEAJun 08Sale87.6446,6004,083,87939,088Jun 10 04:17 PM
Frye AndrewSVP, President, APACJun 03Sale91.003,742340,52216,216Jun 05 04:02 PM
Mason Jeanne KSVP, Human ResourcesApr 27Option Exercise28.9747,1461,365,820163,485Apr 29 04:03 PM
Mason Jeanne KSVP, Human ResourcesApr 27Sale93.1347,1464,390,608116,339Apr 29 04:03 PM